- Filed
- Sep 13, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Sep 11, 2024 | 193.91M sh |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $69M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $0 |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $293.57M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $200.11M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $500.44M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $424.62M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $271.6M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $281.69M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $631.48M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $619.16M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $221.76M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $239.05M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 103.3M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $232K |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2023 | −$71.36M |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | $290.42M |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | $134.33M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | $0.18 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | $0.18 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $37.47M |
| Rd Expense restated | Q1 2024 · Mar 31, 2023 | $41.59M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | $18.93M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | $10.75M |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | −$3.13M |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $5.51M |
| Revenue | Q1 2024 · Mar 31, 2023 | $2.3M |